Arbutus Biopharma Corp Stock Price on April 4, 2024
| ABUS Stock | USD 2.77 0.00 0.00% |
Below is the normalized historical share price chart for Arbutus Biopharma Corp extending back to July 23, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arbutus Biopharma stands at 2.77, as last reported on the 29th of April, with the highest price reaching 2.78 and the lowest price hitting 2.70 during the day.
If you're considering investing in Arbutus Stock, it is important to understand the factors that can impact its price. Arbutus Biopharma appears to be relatively risky, given 3 months investment horizon. Arbutus Biopharma Corp secures Sharpe Ratio (or Efficiency) of 0.0683, which signifies that the company had a 0.0683% return per unit of standard deviation over the last 3 months. We have found twenty-seven technical indicators for Arbutus Biopharma Corp, which you can use to evaluate the volatility of the firm. Please makes use of Arbutus Biopharma's risk adjusted performance of 0.0625, and Mean Deviation of 2.03 to double-check if our risk estimates are consistent with your expectations.
At this time, Arbutus Biopharma's Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 174.3 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 124.4 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 1.38 in 2024, whereas Price To Sales Ratio is likely to drop 13.01 in 2024. Arbutus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of August 2015 | 200 Day MA 2.2724 | 50 Day MA 2.765 | Beta 2.087 |
Arbutus |
Sharpe Ratio = 0.0683
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABUS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.07 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Arbutus Biopharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arbutus Biopharma by adding it to a well-diversified portfolio.
Price Book 4.9455 | Enterprise Value Ebitda (5.64) | Price Sales 28.9019 | Shares Float 115.8 M | Wall Street Target Price 4.4 |
Arbutus Biopharma Main Headline on 4th of April 2024
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But C... by benzinga.com
Moderna stock falls 2.32 percent due to patent infringement suit. However, some investors see this as an opportunity to enter or average out. Golden Cross formation also offers hope for future growth.
Arbutus Biopharma Valuation on April 4, 2024
It is possible to determine the worth of Arbutus Biopharma on a given historical date. On April 4, 2024 Arbutus was worth 2.93 at the beginning of the trading date compared to the closed value of 3.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arbutus Biopharma stock. Still, in general, we apply an absolute valuation method to find Arbutus Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arbutus Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arbutus Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 2.51 | 3.25 | 2.30 | 2.92 | 12,477,260 | |
04/04/2024 | 2.93 | 3.11 | 2.86 | 3.00 | 8,083,973 |
| 3.02 | 3.29 | 2.98 | 3.12 | 6,082,978 |
| Backtest Arbutus Biopharma | | | Arbutus Biopharma History | | | Arbutus Biopharma Valuation | Previous | Next |
Arbutus Biopharma Trading Date Momentum on April 4, 2024
| On April 05 2024 Arbutus Biopharma Corp was traded for 3.12 at the closing time. The top price for the day was 3.29 and the lowest listed price was 2.98 . The trading volume for the day was 6.1 M. The trading history from April 5, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 4.00% . The overall trading delta against the current closing price is 3.33% . |
Arbutus Biopharma Corp Fundamentals Correlations and Trends
By evaluating Arbutus Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arbutus Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arbutus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arbutus Biopharma Stock history
Arbutus Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arbutus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arbutus Biopharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arbutus Biopharma stock prices may prove useful in developing a viable investing in Arbutus Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 166 M | 174.3 M | |
| Net Loss | -62.5 M | -65.6 M |
Arbutus Biopharma Quarterly Net Working Capital |
|
Arbutus Biopharma Stock Technical Analysis
Arbutus Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arbutus Biopharma Period Price Range
Low | April 4, 2024
| High |
2.93 | 3.00 |
Arbutus Biopharma April 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Arbutus Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arbutus Biopharma shares will generate the highest return on investment. By undertsting and applying Arbutus Biopharma stock market strength indicators, traders can identify Arbutus Biopharma Corp entry and exit signals to maximize returns
| Accumulation Distribution | 649837.0 | |||
| Daily Balance Of Power | 0.28 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 2.99 | |||
| Day Typical Price | 2.99 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | (0.23) |
Arbutus Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arbutus Biopharma's price direction in advance. Along with the technical and fundamental analysis of Arbutus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arbutus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0625 | |||
| Jensen Alpha | 0.1438 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0859 | |||
| Treynor Ratio | 0.1743 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arbutus Biopharma Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Arbutus Stock analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Arbutus Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arbutus Biopharma. If investors know Arbutus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arbutus Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Revenue Per Share 0.109 | Quarterly Revenue Growth (0.66) | Return On Assets (0.29) | Return On Equity (0.60) |
The market value of Arbutus Biopharma Corp is measured differently than its book value, which is the value of Arbutus that is recorded on the company's balance sheet. Investors also form their own opinion of Arbutus Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arbutus Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arbutus Biopharma's market value can be influenced by many factors that don't directly affect Arbutus Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arbutus Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Arbutus Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arbutus Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.